How can a lab capture the current clinical and genetic expertise into an accurate diagnostics tool? As science moves forward, panels must be constantly improved and reviewed to ensure that the latest genetic knowledge is integrated. Eveliina Salminen, Clinical Interpretation team leader, and Samuel Myllykangas, Chief Technology Officer at Blueprint Genetics, discuss what to take into account when designing new panels to match clinical needs. “Many of the genes we have been currently adding are only very recently identified as clinically relevant. You really need to go to publications and investigate”, says Eveliina Salminen.
Eveliina is the Head of Clinical interpretation and Clinical geneticist at Blueprint Genetics. She obtained her Ph.D on genetics of multiple epiphyseal dysplasia and osteoarthritis in 2005 followed by post-doctoral studies concentrated on genetics of multiple sclerosis, population genetics and Mendelian disease-gene mapping at the Broad Institute, MA, USA and National Public Health Institute, Helsinki, Finland. Eveliina has also worked as a geneticist in Finnish Genome Center in Helsinki with genome-wide and custom SNP chip projects doing project planning, management, genotyping and data analysis. She has Specialist training in Clinical genetics: both clinical (Dept of Clinical Genetics and Prenatal diagnostic unit, Helsinki University Central Hospital) and laboratory experience (HUSLAB, Laboratory of genetics).
Samuel is the Chief Strategy Officer at Blueprint Genetics as well as a co-founder of the company. He is an expert in genome analysis technologies and has extensive experience in bioinformatics and cancer genomics research. Samuel received his PhD from the University of Helsinki and completed his post-doctoral research at Stanford University. At Stanford, he developed high-throughput sequencing technologies such as the Oligonucleotide-Selective Sequencing (OS-Seq™). He is an adjunct professor in genetics at the University of Helsinki, an author of several high-impact publications, and an inventor in patents of DNA sequencing methods.